Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare haematological malignancy
derived from the precursors of plamacytoid dendritic cells, with an aggressive clinical course …

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an extremely rare tumour, which
usually affects elderly males and presents in the skin with frequent involvement of the bone …

Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy characterized
by the clonal expansion of myeloid blasts in the peripheral blood, bone marrow, and/or other …

The objective of this study was to evaluate the clinical features, prognostic factors, and
efficacy of treatments in patients with blastic plasmacytoid dendritic cell neoplasm with a …

Background Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare disease
characterized by malignant proliferation of a contingent blastic plasmacytoid dendritic cell …

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare disease of controversial
origin recently recognized as a neoplasm deriving from plasmacytoid dendritic cells (pDCs) …

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an uncommon hematologic
malignancy with poor outcomes. Existing data on the clinical behavior of BPDCN are limited …

Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical
implications - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI …

The purpose of this study is to describe the clinical and prognostic features and to evaluate
the outcome of different therapeutic approaches among patients with blastic plasmacytoid …

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare subtype of
leukemia/lymphoma, whose diagnosis can be difficult to achieve due to its clinical and …